Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam
- PMID: 1226625
Item in Clipboard
Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam
Trans Am Neurol Assoc.
1975.
No abstract available
Similar articles
-
A comparison of dantrolene sodium and diazepam in the treatment of spasticity.Paraplegia. 1974 Nov;12(3):170-4. doi: 10.1038/sc.1974.27. Paraplegia. 1974. PMID: 4616209 Clinical Trial. No abstract available.
-
Comparison of dantrolene sodium and diazepam in the treatment of spasticity.J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):350-6. doi: 10.1136/jnnp.39.4.350. J Neurol Neurosurg Psychiatry. 1976. PMID: 778344 Free PMC article. Clinical Trial.
-
Dantrolene sodium: long-term effects in severe spasticity.Arch Phys Med Rehabil. 1973 Jul;54(7):311-5. Arch Phys Med Rehabil. 1973. PMID: 4577936 Clinical Trial. No abstract available.
-
Clinical assessment and pharmacologic therapy of spasticity.Arch Phys Med Rehabil. 1974 Aug;55(8):344-54. Arch Phys Med Rehabil. 1974. PMID: 4277407 Review. No abstract available.
-
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.Drugs. 1977 Jan;13(1):3-23. doi: 10.2165/00003495-197713010-00002. Drugs. 1977. PMID: 318989 Review.
Cited by
-
Anti-spasticity agents for multiple sclerosis.Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD001332. doi: 10.1002/14651858.CD001332. PMID: 11034714 Free PMC article. Updated.